Hanneke W.M. van Laarhoven

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial

Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof et al. · The Lancet Oncology · 2015 · 2.5K citations

Surgical Oncology, Neoadjuvant Chemoradiotherapy, Esophageal Cancer +9

Venous thromboembolism in cancer patients: a population-based cohort study

Frits I. Mulder, Erzsébet Horváth–Puhó, Nick van Es et al. · Blood · 2020 · 641 citations · Full text

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial

Annemieke Cats, Edwin P. M. Jansen, Nicole C.T. van Grieken et al. · The Lancet Oncology · 2018 · 562 citations

Surgical Oncology, Chemotherapy Versus Chemoradiotherapy, Gastrointestinal Oncology +8

Artificial reporter gene providing MRI contrast based on proton exchange

Assaf A. Gilad, Michael T. McMahon, Piotr Walczak et al. · Nature Biotechnology · 2007 · 402 citations

Nuclear Imaging, Engineering, Medical Imaging +10

The assessment of fatigue: Psychometric qualities and norms for the Checklist individual strength

Margreet Worm-Smeitink, Marieke Gielissen, Lotte Bloot et al. · Journal of Psychosomatic Research · 2017 · 358 citations

Physical Activity, Kinesiology, Fatigue Management +12